The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim analysis of CaboMain: A prospective, single-arm phase 2 clinical trial of cabozantinib as maintenance therapy for patients with “ultra-high-risk” pediatric solid tumors.
 
Nilay Shah
Honoraria - Bayer; Fennec Pharma
Research Funding - Exelixis (Inst)
Travel, Accommodations, Expenses - Cardinal Health
 
Elizabeth Alva
No Relationships to Disclose
 
Matthew Dietz
No Relationships to Disclose
 
AeRang Kim
Research Funding - Ascentage Pharma (Inst); AstraZeneca Rare Disease (Inst); Jazz Pharmaceuticals (Inst); Valent Technologies (Inst)
 
Alice Lee
No Relationships to Disclose
 
Emily Blauel-Bocko
No Relationships to Disclose
 
Micah Skeens
No Relationships to Disclose